[Isolation and preliminary identification of stem-like cells in pituitary adenoma]. 2013

Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China.

OBJECTIVE To isolate and identify the pituitary adenoma stem-like cells from pituitary adenoma tissue. METHODS Total RNA was prepared with 42 cases of pituitary adenoma tissue samples frozen in liquid nitrogen, the expression of Nestin was detected by RT-PCR. Tumor spheres were cultured in serum-free conditions and the immunefluorescence were used to detect the expression of stem cell markers such as Nestin, Sox2. RESULTS The positive rate of Nestin mRNA expression was 88.1% (37/42). The cultured tumor spheres were found positive for Nestin, Sox2 by immunefluorescence detection. CONCLUSIONS Stem cell markers are expressed in the pituitary adenoma tissue and the pituitary adenoma stem-like cells can be cultured in serum-free condition.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
January 2009, Methods in molecular biology (Clifton, N.J.),
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
February 2023, Acta neuropathologica communications,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
January 2008, Pathology, research and practice,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
May 2012, Journal of neurosurgery,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
January 2011, Neuroendocrinology,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
November 2016, Acta neuropathologica communications,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
April 2009, Stem cells and development,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
January 2020, Frontiers in endocrinology,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
August 1997, Neurological research,
Pei-Zhi Zhou, and Wei-Chao Ma, and Xiu-Jie Wang, and Shu-Wen Cheng, and Shu Jiang
December 2007, Cellular & molecular immunology,
Copied contents to your clipboard!